FOLFOX chemotherapy (leucovorin/5-fluorouracil/oxaliplatin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FOLFOX chemotherapy (leucovorin/5-fluorouracil/oxaliplatin), covering 2026-03-03 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer [Phase 4]